| P2093 | author name string | Jonathan C Gewirtz | |
| | Andrew C Harris | |
| P2860 | cites work | Addiction and the brain: The neurobiology of compulsion and its persistence | Q22337278 |
| | Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path | Q24538964 |
| | Bidirectional synaptic plasticity: from theory to reality | Q24675727 |
| | Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal | Q28379331 |
| | The neural basis of drug craving: an incentive-sensitization theory of addiction | Q29547475 |
| | Drug abuse: hedonic homeostatic dysregulation | Q29615904 |
| | Drug addiction, dysregulation of reward, and allostasis | Q29616741 |
| | New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata | Q30461561 |
| | The role of the striatopallidal and extended amygdala systems in drug addiction | Q33692839 |
| | Toward a molecular explanation for long-term potentiation. | Q33763096 |
| | In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists. | Q33856557 |
| | Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons | Q33949219 |
| | Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies | Q34022923 |
| | Molecular neurobiology of addiction | Q34093147 |
| | Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine | Q34100505 |
| | Cellular and synaptic adaptations mediating opioid dependence. | Q34127771 |
| | Conditioned suppression by a stimulus associated with nalorphine in morphine-dependent monkeys | Q34280419 |
| | A comparison of withdrawal in rats implanted with different types of morphine pellets | Q68295410 |
| | Acute physical dependence in the waking dog after a single low dose of morphine | Q68927842 |
| | Studies on physical dependence inducible by hours exposure of mice to morphine | Q69113185 |
| | Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats | Q69128878 |
| | Morphine physical dependence unaltered by previous dependence on morphine | Q69196294 |
| | Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats | Q69702618 |
| | Antagonism of morphine tolerance and dependence by metoclopramide | Q69760718 |
| | Effects of dapiprazole, clonidine and yohimbine on the development of dependence and withdrawal behaviour in mice | Q69953056 |
| | Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine | Q70119139 |
| | Agonists and antagonists of adenosine receptors and morphine withdrawal syndrome in rats | Q70485435 |
| | The effects of cholinergic compounds on the development of morphine tolerance, dependence and increased naloxone potency in mice | Q70645558 |
| | Opiate dependence following acute injections of morphine and naloxone: the assessment of various withdrawal signs | Q70662606 |
| | Influence of clonidine on the acute dependence response elicited in naive rats by naloxone | Q71229340 |
| | A preliminary description of acute physical dependence on morphine in the vervet monkey | Q71229513 |
| | Naloxone-precipitated abstinence in mice, rats and gerbils acutely dependent on morphine | Q71241207 |
| | Acute physical dependence: Time course and relation to human plasma morphine concentrations* | Q72113261 |
| | Effects of N-methylnaloxone and N-methylanaltrexone on nociception and precipitated abstinence in mice | Q72682233 |
| | Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal | Q73553698 |
| | Modification of naloxone-precipitated withdrawal symptoms in mice by drugs acting on alpha(2)-adrenoceptors | Q73554056 |
| | Microinjections of an opiate receptor antagonist into the bed nucleus of the stria terminalis suppress heroin self-administration in dependent rats | Q73718310 |
| | Acute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine tolerance | Q73746717 |
| | Acute dependence on, but not tolerance to, heroin and morphine as measured by respiratory effects in rhesus monkeys | Q73901708 |
| | Opiate withdrawal in the neonatal rat: relationship to duration of treatment and naloxone dose | Q74102728 |
| | Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time | Q77337185 |
| | Molecular and cellular basis of addiction | Q34440561 |
| | The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependence | Q34455963 |
| | Neural systems underlying opiate addiction. | Q34616139 |
| | Inhibition by naloxone of tolerance and dependence in mice treated acutely and chronically with morphine | Q39146217 |
| | Ethoexperimental approaches to the biology of emotion | Q39466488 |
| | Pharmacology of opioids. | Q40093863 |
| | Under siege: The brain on opiates | Q40986699 |
| | Naltrexone-sensitizing effects of centrally administered morphine and opioid peptides | Q41134380 |
| | Estrogen and parathyroid hormone regulate insulin-like growth factor binding protein-4 in SaOS-2 cells | Q41138960 |
| | Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene | Q41157124 |
| | Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal | Q41211959 |
| | Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats. | Q41229776 |
| | Enhanced sensitivity to behavioral effects of naltrexone in rats. | Q41241771 |
| | Reinforcement processes in opiate addiction: a homeostatic model | Q41247900 |
| | Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence | Q41310211 |
| | Ketanserin and pirenperone attenuate acute morphine withdrawal in rats | Q41480243 |
| | Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence | Q41507059 |
| | Opposing roles of the amygdala and dorsolateral periaqueductal gray in fear-potentiated startle | Q41672181 |
| | Differential expression of response-disruptive and somatic indices of opiate withdrawal during the initiation and development of opiate dependence. | Q41732102 |
| | Morphine dependence with or without tolerance in formalin-treated mice: further evidence for the dissociation. | Q42280984 |
| | Acute tolerance associated with a single opiate administration: involvement of N-methyl-D-aspartate-dependent pain facilitatory systems | Q42543643 |
| | Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence | Q42687504 |
| | Changes in urination/defecation, auditory startle response, and startle-induced ultrasonic vocalizations in rats undergoing morphine withdrawal: similarities and differences between acute and chronic dependence | Q43360318 |
| | Tolerance and dependence after continuous morphine infusion from osmotic pumps measured by operant responding in rats | Q43527791 |
| | Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent | Q43579998 |
| | Anxiogenic-like effects of opiate withdrawal seen in the fear-potentiated startle test, an interdisciplinary probe for drug-related motivational states | Q43658247 |
| | Effects of a selective kappa-opioid agonist, U-50,488H, on morphine dependence in rats | Q43700136 |
| | Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated | Q43705022 |
| | Assessment of acute and chronic morphine dependence in male and female mice | Q43744077 |
| | Attenuation of acute morphine withdrawal in the neonatal rat by the competitive NMDA receptor antagonist LY235959. | Q43890425 |
| | The aversive properties of acute morphine dependence persist 48 h after a single exposure to morphine: evaluation by taste and place conditioning | Q43921579 |
| | Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure | Q43923290 |
| | Properties of LTD and LTP of retinocollicular synaptic transmission in the developing rat superior colliculus | Q44004708 |
| | Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal | Q44035207 |
| | The effects of dopamine receptor agents on naloxone-induced jumping behaviour in morphine-dependent mice | Q44145465 |
| | Modification of morphine-induced analgesia, tolerance and dependence by bromocriptine | Q44232303 |
| | Neural organization of the defensive behavior system responsible for fear | Q44272854 |
| | Increased antagonist potency of naloxone caused by morphine pretreatment in mice | Q44295318 |
| | Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence | Q44327368 |
| | Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice | Q44333988 |
| | Opioid physical dependence development: effects of single versus repeated morphine pretreatments and of subjects' opioid exposure history | Q44335737 |
| | Opioid physical dependence development in humans: effect of time between agonist pretreatments | Q44335983 |
| | Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs | Q44337557 |
| | Acute sensitization to opioid antagonists | Q44338779 |
| | Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval II. | Q44338876 |
| | Involvement of delta 2 opioid receptors in the development of morphine dependence in mice | Q44339852 |
| | Involvement of delta 2 opioid receptors in acute dependence on morphine in mice. | Q44340082 |
| | Mianserin and trazodone significantly attenuate the intensity of opioid withdrawal symptoms in mice. | Q44341558 |
| | Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval. I. | Q44341716 |
| | Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal | Q44341762 |
| | DPDPE-UK14,304 synergy is retained in mu opioid receptor knockout mice | Q44342171 |
| | An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice | Q44343549 |
| | Repeated experience with naloxone facilitates acute morphine withdrawal: potential role for conditioning processes in acute opioid dependence | Q44343709 |
| | Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine. | Q44344922 |
| | Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence | Q44345146 |
| | The delta agonists DPDPE and deltorphin II recruit predominantly mu receptors to produce thermal analgesia: a parallel study of mu, delta and combinatorial opioid receptor knockout mice | Q44345198 |
| | Direct dependence studies in rats with agents selective for different types of opioid receptor. | Q44345241 |
| | Intracranial self-stimulation in rats: sensitization to an opioid antagonist following acute or chronic treatment with mu opioid agonists. | Q44345432 |
| | Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence | Q44346816 |
| | Antisense oligodeoxynucleotide to delta opioid receptors attenuates morphine dependence in mice | Q44346877 |
| | Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists | Q44350688 |
| | Tolerance to Opioid Narcotics: Time Course and Reversibility of Physical Dependence in Mice | Q44351294 |
| | Role of spinal mu opioid receptors in the development of morphine tolerance and dependence | Q44351603 |
| | Locomotor activity and antinociception after putative mu, kappa and sigma opioid receptor agonists in the rat: influence of dopaminergic agonists and antagonists | Q44352827 |
| | Morphine and cocaine influence on CRF biosynthesis in the rat central nucleus of amygdala | Q44441662 |
| | Blocking naloxone-precipitated withdrawal in rats and hamsters | Q44547681 |
| | Elevated startle during withdrawal from acute morphine: a model of opiate withdrawal and anxiety | Q44588986 |
| | A non-invasive gating device for continuous drug delivery that allows control over the timing and duration of spontaneous opiate withdrawal. | Q44799387 |
| | In rats, acute morphine dependence results in antagonist-induced response suppression of intracranial self-stimulation | Q44801597 |
| | Potentiated startle and hyperalgesia during withdrawal from acute morphine: effects of multiple opiate exposures | Q44911348 |
| | Withdrawal-induced c-Fos expression in the rat centromedial amygdala 24 h following a single morphine exposure | Q44919932 |
| | Conditioned fear and startle magnitude: effects of different footshock or backshock intensities used in training | Q45027845 |
| | Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. | Q46316515 |
| | The role of dopamine in the expression of morphine withdrawal | Q46413067 |
| | Role of different brain structures in the expression of the physical morphine withdrawal syndrome | Q46526505 |
| | A comparison of the effects of naloxone upon body weight loss and suppression of fixed-ratio operant behavior in morphine-dependent rats | Q47330618 |
| | Effects of intracerebroventricular clonidine on the hypothalamic noradrenaline and plasma corticosterone levels of opiate naive rats and after naloxone-induced withdrawal | Q48106969 |
| | Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. | Q48159688 |
| | Effects of acute and chronic morphine treatments on calcium localization and binding in brain | Q48193404 |
| | Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the rat. | Q48218897 |
| | Calcium-dependent mechanisms involved in presynaptic long-term depression at the hippocampal mossy fibre-CA3 synapse. | Q48228504 |
| | Changes in response rates and reinforcement thresholds for intracranial self-stimulation during morphine withdrawal | Q48267210 |
| | Reinitiation of sensitivity to naloxone by a single narcotic injection in postaddicted mice | Q48390167 |
| | Indomethacin facilitates acute tolerance to and dependence upon morphine as measured by changes in fixed-ratio behavior and rectal temperature in rats | Q48480601 |
| | Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists | Q48485454 |
| | An analysis of precipitated withdrawal in rats acutely dependent on morphine. | Q48503716 |
| | Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray. | Q48617076 |
| | Sex-related differences in morphine's antinociceptive activity: relationship to serum and brain morphine concentrations | Q48649920 |
| | Effects of trazodone and m-chlorophenylpiperazine (m-CPP) on acute dependence in mice | Q48727802 |
| | Catecholamine utilization in distinct mouse brain nuclei during acute morphine treatment, morphine tolerance and withdrawal syndrome | Q48736923 |
| | Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion. | Q49148655 |
| | Anxiogenic-like effects of spontaneous and naloxone-precipitated opiate withdrawal in the elevated plus-maze. | Q51095545 |
| | Comparative clinical pharmacology of short-acting mu opioids in drug abusers. | Q51570580 |
| | Further studies on the acute dependence produced by morphine in opiate naive rats. | Q51858679 |
| | Reversal of morphine anesthesia with naloxone. | Q52115689 |
| | Conditioned place aversion to the "hangover" phase of acute ethanol administration in the rat. | Q52143782 |
| | Discriminative stimulus effects of naltrexone after a single dose of morphine in the rat. | Q52179253 |
| | Naloxone-precipitated morphine withdrawal induced place aversions: effect of naloxone at 24 hours postmorphine. | Q52183425 |
| | Conditioned sucrose aversions produced by naloxone-precipitated withdrawal from acutely administered morphine. | Q52191628 |
| | Opiate withdrawal signs precipitated by naloxone following a single exposure to morphine: potentiation with a second morphine exposure. | Q52197423 |
| | Chlordiazepoxide, but not bretazenil, produces acute dependence, as evidenced by disruptions in schedule-controlled behavior. | Q52216252 |
| | Naloxone pretreatment blocks acute morphine-induced sensitization to naltrexone. | Q52218222 |
| | Effects of acute morphine pretreatment on the rate-decreasing and antagonist activity of naloxone. | Q52263911 |
| | Yohimbine exacerbates and clonidine attenuates acute morphine withdrawal in rats. | Q52280948 |
| | Effects of single doses of N-Allylnormorphine on hindlimb reflexes of chronic spinal dogs during cycles of morphine addiction. | Q52282999 |
| | A COMPARISON BETWEEN ACUTE AND CHRONIC PHYSICAL DEPENDENCE IN THE CHRONIC SPINAL DOG | Q52284675 |
| | Evidence of possible opiate dependence during the behavioral depressant action of a single dose of morphine | Q52306304 |
| | Conditioned narcotic withdrawal in humans. | Q52307240 |
| | Dynamics of drug dependence. Implications of a conditioning theory for research and treatment. | Q52321865 |
| | Morphine: Conditioned Increases in Self-Administration in Rhesus Monkeys | Q52334647 |
| | Naloxone for antagonism of morphine-induced respiratory depression. | Q52730134 |
| | Plasma catecholamine concentrations during morphine withdrawal in conscious guinea-pigs. | Q53876155 |
| | Methadone-naloxone mixtures for use in methadone maintenance programs. I. An evaluation in man of their pharmacological feasibility. II. Demonstration of acute physical dependence. | Q53971436 |
| | Naloxone-precipitated jumping activity in mice following the acute administration of morphine. | Q54459973 |
| | Modification of Morphine Withdrawal by Drugs interacting with Humoral Mechanisms: Some Contradictions and their Interpretation | Q59049226 |
| | Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion | Q59080348 |
| | Persistent protein kinase activity underlying long-term potentiation | Q59091750 |
| | Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists | Q60682497 |
| | Naloxone-precipitated jumping in mice pretreated with acute injections of opioids | Q66946387 |
| | Morphine no longer blocks gastrointestinal transit but retains antinociceptive action in diallylnormorphine-pretreated rats | Q66972321 |
| | The role of the cholinergic system in the development of increased naloxone potency in mice | Q67016246 |
| | Antagonism by naloxone of tolerance and dependence in mice given a single dose of morphine | Q67020204 |
| | Quantitation of physical dependence in mice by naloxone-precipitated jumping after a single dose of morphine | Q67298072 |
| | Influence of different benzodiazepines on the experimental morphine abstinence syndrome | Q67649873 |
| | Differential effects of L-type calcium channel blockers and stimulants on naloxone-precipitated withdrawal in mice acutely dependent on morphine | Q67701864 |
| | Acute morphine dependence in the hamster | Q67943143 |
| | Ultrasounds during morphine withdrawal in rats | Q67952568 |
| | Acute physical dependence in man: effects of naloxone after brief morphine exposure | Q68250786 |
| P433 | issue | 4 | |
| P304 | page(s) | 353-366 | |
| P577 | publication date | 2005-02-05 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal | |
| P478 | volume | 178 | |